Advertisement
Advertisement
LNTH
Lantheus Holdings, Inc
78.03
USDSponsored
+2.14
+2.82%
Apr 07, 16:00 UTC -4
Closed
After-Market
78.93
+0.91
+1.16%
LNTH Earnings Reports
Positive Surprise Ratio
LNTH beat 34 of 41 last estimates.
83%
Next Report
Date of Next Report
May 05, 2026
Estimate for Q1 26 (Revenue/ EPS)
$362.00M
/$1.26
Implied change from Q4 25 (Revenue/ EPS)
-11.01%
/-24.55%
Implied change from Q1 25 (Revenue/ EPS)
-2.89%
/-17.65%
Lantheus Holdings, Inc earnings per share and revenue
On Feb 26, 2026, LNTH reported earnings of 1.67 USD per share (EPS) for Q4 25, beating the estimate of 1.19 USD, resulting in a 40.22% surprise. Revenue reached 406.79 million, compared to an expected 375.18 million, with a 8.43% difference. The market reacted with a -0.38% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 10 analysts forecast an EPS of 1.26 USD, with revenue projected to reach 362.00 million USD, implying an decrease of -24.55% EPS, and decrease of -11.01% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lumexa Imaging Holdings, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
$0.07
Actual
-$0.20
Surprise
-374.35%
Omeros Corporation
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.58
Actual
$0.98
Surprise
+268.56%
Tilray Brands, Inc. Common Stock
Report Date
Apr 01, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.24
Surprise
-68.07%
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.09
Surprise
-19.79%
SANUWAVE Health, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
$0.17
Actual
$0.89
Surprise
+413.26%
Oramed Pharmaceuticals Inc.
Report Date
Mar 26, 2026 For Q4 25
Estimate
$0.00
Actual
$0.24
Surprise
0.00%
FitLife Brands, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.21
Actual
$0.16
Surprise
-25.22%
Rockwell Medical, Inc. (DE) Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.01
Surprise
-149.02%
Cytosorbents Corp.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.09
Surprise
-76.47%
Innovative Eyewear, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.43
Actual
-$0.14
Surprise
+68.08%
FAQ
What were Lantheus Holdings, Inc's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Lantheus Holdings, Inc reported EPS of $1.67, beating estimates by 40.22%, and revenue of $406.79M, 8.43% above expectations.
How did the market react to Lantheus Holdings, Inc's Q4 2025 earnings?
The stock price moved down -0.38%, changed from $75.72 before the earnings release to $75.43 the day after.
When is Lantheus Holdings, Inc expected to report next?
The next earning report is scheduled for May 05, 2026.
What are the forecasts for Lantheus Holdings, Inc's next earnings report?
Based on 10
analysts, Lantheus Holdings, Inc is expected to report EPS of $1.26 and revenue of $362.00M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement